Parents’ and Health Professionals’ Attitudes to Advancing Primary MMR Vaccine Administration from Fifteen to Six Months of Age—A Qualitative Thematic Analysis Embedded in a Randomized Trial

Declining levels and duration of passively acquired maternal antibodies prompted a Danish trial to test the feasibility of advancing administration of the first measles, mumps, and rubella vaccine (MMR1) from 15 to 6 months of age. A trial-embedded qualitative study aimed to understand parents’ (<...

Full description

Bibliographic Details
Main Authors: Ann-Britt Kiholm Kirkedal, Julie Elkjær Møller, Lone Graff Stensballe, Vibeke Zoffmann
Format: Article
Language:English
Published: MDPI AG 2022-12-01
Series:Vaccines
Subjects:
Online Access:https://www.mdpi.com/2076-393X/11/1/67